Melitro

Bisacodyl, the active ingredient in Melitro, is a stimulant laxative presented as an oral tablet for oral use. It is used to relieve constipation and to aid bowel cleansing before medical procedures in adults and children when appropriate. GNH USA supplies Melitro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melitro (bisacodyl) acts on the lower gastrointestinal tract to facilitate bowel movements and is indicated for conditions requiring increased colonic motility. - Constipation: provides relief of infrequent or difficult bowel movements. - Occasional constipation: helps restore regularity in mild cases. - Bowel preparation: assists in cleansing the colon prior to diagnostic or surgical procedures.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps or pain - Diarrhea or loose stools - Nausea or mild stomach upset - Increased thirst or mild dehydration

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Allergic reactions such as rash or swelling - Colonic perforation in cases of misuse - Persistent abdominal pain requiring medical evaluation

When using bisacodyl, consider the following safety measures to minimize risks. - Assess renal function: adjust use in patients with renal impairment. - Avoid in intestinal obstruction: contraindicated where blockage exists. - Use with caution in the elderly: increased susceptibility to dehydration. - Do not exceed recommended frequency: follow prescriber guidance. - Store at ambient temperature: keep in the original pack, protect from moisture.

Bisacodyl can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effectiveness. - Loop diuretics: increase risk of electrolyte disturbances. - Cardiac glycosides: heightened risk of arrhythmia due to electrolyte shifts.

Moderate Interactions (Monitor Closely): - Magnesium‑containing antacids: may potentiate laxative effect. - Corticosteroids: may increase risk of colonic perforation.